Life science companies continually evaluate their operations for opportunities to improve throughput, increase compliance, and reduce costs. Medical device manufacturers, laboratories, and R&D facilities can all experience greater flexibility and more control with an in-house ethylene oxide (EO) sterilization program. By reducing what can be a two-week turnaround time with outsourced sterilization, operations managers can expect faster release of finished goods and increased inventory turns for a measurable and sustainable economic benefit. In particular, companies that process small, high-value devices can benefit from the new 3M™ Steri-Vac™ Sterilizer/Aerator GSX Series ethylene oxide (EO) sterilization system, with state-of-the-art mechanical design, real-time cycle information on the high-resolution color touch screen, and the ability to quickly and easily customize sterilization cycles.